Barinthus Biotherapeutics plc (BRNS) — Free Cash Flow Generation Index
Latest as of December 2024:
0.98x
Barinthus Biotherapeutics plc (BRNS) has a Free Cash Flow Generation Index of 0.98x as of December 2024. Free cash flow of $12.81 Million represents 1% of operating cash flow ($13.09 Million). See BRNS working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
0.98x
Free Cash Flow / Operating CF
Free Cash Flow
$12.81 Million
USD
Operating Cash Flow
$13.09 Million
USD
Capital Expenditures
$278.00K
USD
Annual Free Cash Flow Generation for Barinthus Biotherapeutics plc (None–None)
Year-by-year Free Cash Flow Generation Index for Barinthus Biotherapeutics plc. For the full company profile including market capitalisation, see BRNS market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).